γ-Glutamylamines and neurodegenerative diseases.

Amino Acids

Neurosciences, Biomedical Research Core, Winthrop University Hospital, 222 Station Plaza North, Mineola, USA.

Published: January 2013

Transglutaminases catalyze the formation of γ-glutamylamines utilizing glutamyl residues and amine-bearing compounds such as lysyl residues and polyamines. These γ-glutamylamines can be released from proteins by proteases in an intact form. The free γ-glutamylamines can be catabolized to 5-oxo-L-proline and the free amine by γ-glutamylamine cyclotransferase. Free γ-glutamylamines, however, accumulate in the CSF and affected areas of Huntington Disease brain. This observation suggests transglutaminase-derived γ-glutamylamines may play a more significant role in neurodegeneration than previously thought. The following monograph reviews the metabolism of γ-glutamylamines and examines the possibility that these species contribute to neurodegeneration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491119PMC
http://dx.doi.org/10.1007/s00726-011-1209-3DOI Listing

Publication Analysis

Top Keywords

free γ-glutamylamines
8
γ-glutamylamines
7
γ-glutamylamines neurodegenerative
4
neurodegenerative diseases
4
diseases transglutaminases
4
transglutaminases catalyze
4
catalyze formation
4
formation γ-glutamylamines
4
γ-glutamylamines utilizing
4
utilizing glutamyl
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!